Seda appoints new CEO as they embark on significant growth period
Today Seda welcomed their new CEO, Prof Paul W Stott . Paul joins Seda from his previous role as VP, Global Product Development at AstraZeneca at a time when the company are about to embark on a significant period growth. Seda are progressing with new laboratory and office space at Alderley Park and are in the process of equipping the facility to meet the needs of their client base. Their roster of talent continues to grow with appointments at all levels of the organisation with more to come. Dr Paul Dickinson, Director and Co-Founder, stated “Paul brings a wealth of experience to the team having performed several senior executive roles in big pharma and overseeing the approval and launch of numerous blockbuster medicines. His appointment complements the existing talents at Seda and is a demonstration of our growing presence and ambition.”
Find out more about Seda via their website: http://www.sedapds.com
